The role of probiotics in the management of cardiovascular disease risk factors

The cardiovascular diseases are the most common causes of mortality in the world. Controlling of blood lipid levels is one of the important factors in the prevention and treatment of atherosclerotic disorders. According to available research evidence, probiotics are probably helpful in the improvement of lipid profile and atherosclerotic control. The aim of this study is to review the effect of probiotics strains on lipid profile and atherosclerotic in cardiovascular diseases.There is a strong relationship between the type and number of intestinal microorganisms with cardiovascular histologic health. The type of probiotic is a key factor in significant differences of biochemical markers. The probiotics in addition to prebiotics are likely more effective in improvement of serum lipids. Regarding to basic characteristics of patient and risk factors of dyslipidemia, hypertension, oxidative stress and chronic inflammation, we should decide accurately about the proper dose of probiotics and the length of the intervention period.